Stericycle (NASDAQ:SRCL) had its target price decreased by research analysts at Royal Bank of Canada from $75.00 to $61.00 in a research note issued on Thursday. The firm presently has an “underperform” rating on the business services provider’s stock. Royal Bank of Canada’s price target points to a potential upside of 1.58% from the company’s previous close.
Several other equities research analysts have also recently weighed in on the company. Robert W. Baird upgraded Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 target price for the company in a report on Tuesday, February 13th. BidaskClub upgraded Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. BMO Capital Markets reiterated a “hold” rating and issued a $72.00 target price on shares of Stericycle in a report on Wednesday, January 24th. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $85.00 target price on shares of Stericycle in a report on Thursday, December 28th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $71.50.
Stericycle (NASDAQ SRCL) opened at $60.05 on Thursday. Stericycle has a 1-year low of $58.53 and a 1-year high of $88.00. The company has a current ratio of 0.84, a quick ratio of 0.82 and a debt-to-equity ratio of 0.90. The stock has a market capitalization of $5,176.16, a price-to-earnings ratio of 230.97, a P/E/G ratio of 1.46 and a beta of 0.26.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Wednesday, February 21st. The business services provider reported $1.00 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.14). Stericycle had a net margin of 1.18% and a return on equity of 13.83%. The business had revenue of $887.80 million for the quarter, compared to analysts’ expectations of $882.62 million. During the same quarter in the previous year, the firm earned $1.00 EPS. Stericycle’s revenue was down 2.1% compared to the same quarter last year. equities analysts expect that Stericycle will post 4.54 earnings per share for the current year.
In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $63.33, for a total value of $1,250,957.49. Following the completion of the sale, the director now directly owns 205,854 shares in the company, valued at approximately $13,036,733.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.50% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. First Merchants Corp bought a new position in shares of Stericycle in the 3rd quarter worth $1,483,000. California Public Employees Retirement System raised its position in shares of Stericycle by 2.9% in the 3rd quarter. California Public Employees Retirement System now owns 156,984 shares of the business services provider’s stock worth $11,243,000 after acquiring an additional 4,384 shares in the last quarter. BNP Paribas Arbitrage SA raised its position in shares of Stericycle by 29.2% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 64,921 shares of the business services provider’s stock worth $4,368,000 after acquiring an additional 14,677 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Stericycle by 31.4% in the 2nd quarter. Janus Henderson Group PLC now owns 16,847 shares of the business services provider’s stock worth $1,286,000 after acquiring an additional 4,021 shares in the last quarter. Finally, Stifel Financial Corp raised its position in shares of Stericycle by 15.1% in the 3rd quarter. Stifel Financial Corp now owns 99,039 shares of the business services provider’s stock worth $7,128,000 after acquiring an additional 12,997 shares in the last quarter. 92.57% of the stock is owned by hedge funds and other institutional investors.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.